Notice2021-21036
National Cancer Institute; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 28, 2021
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 185 (Tuesday, September 28, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 185 (Tuesday, September 28, 2021)]
[Notices]
[Page 53666]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-21036]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Frederick National
Laboratory Advisory Committee to the National Cancer Institute.
The meeting will be held virtually and is open to the public.
Individuals who plan to view the virtual meeting and need special
assistance or other reasonable accommodations to view the meeting,
should notify the Contact Person listed below in advance of the
meeting. The meeting will be videocast and can be accessed from the NIH
Videocasting and Podcasting website (<a href="http://videocast.nih.gov">http://videocast.nih.gov</a>).
Name of Committee: Frederick National Laboratory Advisory
Committee to the National Cancer Institute.
Date: October 18, 2021.
Time: 1:00 p.m. to 4:30 p.m.
Agenda: Ongoing and new activities at the Frederick National
Laboratory for Cancer Research.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Rockville, MD 20850 (Virtual Meeting).
Contact Person: Wlodek Lopaczynski, M.D., Ph.D., Assistant
Director, Division of Extramural Activities, National Cancer
Institute, National Institutes of Health, 9609 Medical Center Drive,
Seventh Floor, West Tower, Room 7W514, Bethesda, MD 20892, 240-276-
6458, <a href="/cdn-cgi/l/email-protection#bbd7d4cbdad8ccfbd6dad2d795d5d2d395dcd4cd"><span class="__cf_email__" data-cfemail="325e5d42535145725f535b5e1c5c5b5a1c555d44">[email protected]</span></a>.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: FNLAC: <a href="https://deainfo.nci.nih.gov/advisory/fac/fac.htm">https://deainfo.nci.nih.gov/advisory/fac/fac.htm</a>, where
an agenda and any additional information for the meeting will be
posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: September 23, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-21036 Filed 9-27-21; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 28, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.